血脂管理与ASCVD的回顾与展望

Retrospect and prospect of blood lipid management and ASCVD

更新的血脂指南中,一级预防危险分层引入增强的危险因素,二级预防中动脉粥样硬化性心血管疾病(ASCVD)风险再分层,低密度脂蛋白胆固醇(LDL-C)目标值进一步降低。联合降脂已成为趋势,用药种类、给药方式及治疗靶点均有全新呈现。

In the updated blood lipid guidelines, the risk stratification of primary prevention introduces enhanced risk factors, the risk of atherosclerotic cardiovascular disease(ASCVD) in secondary prevention is further stratified, and the target value of low-density lipoprotein cholesterol(LDL-C) decreases further. Combined lipid-lowering has become a trend. The types of medications, methods of administration and therapeutic targets have been newly presented.